ARCHIVES

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

January 21, 1977

Funding Opportunities.

April 11, 2003

In Brief: Greenwald Reorganizing DCPC, Elevates Surveillance to Program, Moves Branches

February 3, 1989

Medicare Expands Coverage for Lymphedema Pumps.

May 11, 2001

Grantees Not In Danger Of Losing Cost-Free Biological Materials, But Can’t Have Chemicals

September 9, 1977

FDA, NCI Seek Compromise On Survival Endpoints

June 16, 1989